GB201417369D0 - Compounds - Google Patents

Compounds

Info

Publication number: GB201417369D0
Authority: GB; United Kingdom
Prior art keywords: compounds
Prior art date: 2014-10-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1417369.4A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Redx Pharma Ltd

Original Assignee

Redx Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-10-01

Filing date

2014-10-01

Publication date

2014-11-12

2014-10-01 Application filed by Redx Pharma Ltd filed Critical Redx Pharma Ltd

2014-10-01 Priority to GBGB1417369.4A priority Critical patent/GB201417369D0/en

2014-11-12 Publication of GB201417369D0 publication Critical patent/GB201417369D0/en

2015-10-01 Priority to PCT/GB2015/052868 priority patent/WO2016051181A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB1417369.4A 2014-10-01 2014-10-01 Compounds Ceased GB201417369D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB1417369.4A GB201417369D0 (en)	2014-10-01	2014-10-01	Compounds
PCT/GB2015/052868 WO2016051181A1 (en)	2014-10-01	2015-10-01	4h-imidazo[1,5-a]indole derivatives and their use as indoleamine 2,3-dioxygenase (ido) and/or tryptophan 2,3-dioxygenase (td02) modulators

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1417369.4A GB201417369D0 (en)	2014-10-01	2014-10-01	Compounds

Publications (1)

Publication Number	Publication Date
GB201417369D0 true GB201417369D0 (en)	2014-11-12

Family

ID=51901467

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1417369.4A Ceased GB201417369D0 (en)	2014-10-01	2014-10-01	Compounds

Country Status (2)

Country	Link
GB (1)	GB201417369D0 (en)
WO (1)	WO2016051181A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2016248366B2 (en) *	2015-04-12	2019-06-13	Hangzhou Innogate Pharma Co., Ltd.	Heterocycles useful as IDO and TDO inhibitors
EP3400226A1 (en)	2016-02-02	2018-11-14	Emcure Pharmaceuticals Limited	Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter alia cancer
AU2017315572B2 (en)	2016-08-23	2021-07-15	Beijing Innocare Pharma Tech Co., Ltd.	Fused heterocyclic derivative, preparation method therefor and medical use thereof
WO2018054365A1 (en)	2016-09-24	2018-03-29	Beigene, Ltd.	NOVEL 5 or 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES
ES2939646T3 (en)	2016-10-13	2023-04-25	Juno Therapeutics Inc	Immunotherapy methods and compositions comprising modulators of the tryptophan metabolic pathway
PL3559009T3 (en)	2016-12-22	2021-10-25	Calithera Biosciences, Inc.	Compositions and methods for inhibiting arginase activity
JP2020506895A (en)	2017-01-17	2020-03-05	ボードオブレジェンツ, ザユニバーシティオブテキサスシステムBoard Of Regents, The University Of Texas System	Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and / or tryptophan dioxygenase
EP3823604A4 (en)	2018-07-17	2022-03-16	Board of Regents, The University of Texas System	COMPOUNDS USEFUL AS INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHANE DIOXYGENASE INHIBITORS
CN111803635B (en) *	2020-06-17	2023-03-14	中国医学科学院基础医学研究所	Application of small molecule inhibitor in treating respiratory viral pneumonia
BR112023017582A2 (en)	2021-03-05	2023-12-05	Univ Basel	COMPOSITIONS FOR THE TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH EBV
EP4052705A1 (en)	2021-03-05	2022-09-07	Universität Basel Vizerektorat Forschung	Compositions for the treatment of ebv associated diseases or conditions
CN113816965B (en) *	2021-11-23	2022-03-08	北京鑫开元医药科技有限公司	Compound with IDO (indomethacin diphosphate) inhibitory activity and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK124695A3 (en) *	1993-04-08	1996-06-05	Du Pont Merck Pharma	Disubstituted polycyclic compounds and their derivatives alone and for treatment, and pharmaceutical compositions on their base
NO2694640T3 (en) *	2011-04-15	2018-03-17
PE20151593A1 (en) *	2013-03-14	2015-11-05	Newlink Genetics Corp	TRICYCLIC COMPOUNDS AS INHIBITORS OF IMMUNOSUPPRESSION MEDIATED BY TRYPTOPHAN METABOLISM

2014
- 2014-10-01 GB GBGB1417369.4A patent/GB201417369D0/en not_active Ceased
2015
- 2015-10-01 WO PCT/GB2015/052868 patent/WO2016051181A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2016051181A1 (en)	2016-04-07

Publication	Publication Date	Title
AP2017009836A0 (en)	2017-03-31	Aminopyridyloxypyrazole compounds
GB201411418D0 (en)	2014-08-13	Compounds
GB201415573D0 (en)	2014-10-15	Compounds
GB201418300D0 (en)	2014-11-26	Compounds
GB201410430D0 (en)	2014-07-23	Compounds
GB201416186D0 (en)	2014-10-29	Compounds
GB201402431D0 (en)	2014-03-26	Compounds
GB201417561D0 (en)	2014-11-19	Compounds
GB201417369D0 (en)	2014-11-12	Compounds
GB201406591D0 (en)	2014-05-28	Compounds
GB201406956D0 (en)	2014-06-04	Compounds
GB201404987D0 (en)	2014-05-07	Compounds
GB201419228D0 (en)	2014-12-10	Compounds
GB201419264D0 (en)	2014-12-10	Compounds
GB201412660D0 (en)	2014-08-27	Compounds
AP2017009778A0 (en)	2017-03-31	Azetidinyloxyphenylpyrrolidine compounds
GB201504956D0 (en)	2015-05-06	Compounds
GB201419015D0 (en)	2014-12-10	Compounds
GB201407695D0 (en)	2014-06-18	Compounds
GB201405361D0 (en)	2014-05-07	Compounds
GB201707536D0 (en)	2017-06-28	Compounds
GB201421711D0 (en)	2015-01-21	Compounds
GB201421020D0 (en)	2015-01-07	Compounds
GB201421019D0 (en)	2015-01-07	Compounds
GB201420594D0 (en)	2014-12-31	Compounds

Legal Events

Date	Code	Title	Description
2015-10-28	AT	Applications terminated before publication under section 16(1)